Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-29

FDA Approved: WEGOVY — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental application for Wegovy (semaglutide) from Novo Nordisk. The snippet does not specify the exact new indication or labeling changes in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WEGOVY (Semaglutide)

Snippet

SUPPL AP for WEGOVY (SEMAGLUTIDE)